Lazard Asset Management LLC Charles River Laboratories International, Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 7,563 shares of CRL stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,563
Previous 35,050
78.42%
Holding current value
$1.23 Million
Previous $7.24 Million
79.43%
% of portfolio
0.0%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
51.7MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$995 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$830 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$610 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$347 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$316 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...